Lisa Strug, PhD
Tier 1 Canada Research Chair in Genome Data Science
Professor | Department of Statistical Sciences, Computer Science and Dalla Lana School of Public Health, Division of Biostatistics, University of Toronto
Director | Data Sciences Institute (DSI) at University of Toronto
Director of CANSSI Ontario | Faculty of Arts and Science, University of Toronto
Senior Scientist | Genetics and Genome Biology Program, SickKids Research Institute
Associate Director | The Centre for Applied Genomics, SickKids Research Institute
Vector Faculty Affiliate
Communities & Affiliations
The Data Sciences Institute (DSI) is a multi-divisional, tri-campus, multidisciplinary hub for data science activity at the University of Toronto (U of T).
The DSI facilitates research connections, fosters innovation, and enhances teaching and learning in data sciences, including in emerging data-driven disciplines with a highly collaborative, inclusive approach.
They bring together researchers and trainees from across the University, its affiliated research institutes, industry and beyond to support data sciences research, innovation, collaboration, and training to translate promising ideas into real-world solutions and advance the data sciences, themselves. The DSI enhances and capitalizes on U of T’s established data science leadership in a city renowned for its data science expertise.
To learn more about how to become a member and upcoming DSI events and opportunities, check out their website!
CANSSI Ontario’s goal is to strengthen and enhance research and training in data science by developing programs that promote interdisciplinary researchers and enable multidisciplinary collaborations.
CANSSI Ontario provides both province-wide leadership in the development of these programs, and local leadership for data-intensive research within the University of Toronto (U of T) community.
For more information on CANSSI Ontario programs and funding opportunities.
Genetics & Genome Biology (GGB) research at the SickKids Research Institute aims to determine the role genes play in paediatric health by innovating sequencing and disease modeling technologies.
GGB researchers use genetics and genomics to understand human health and disease, as well as genetic and environmental influences on disease risk. The team translates that knowledge to improve child health through treatment or prevention strategies.
Visit their website for more information about the Genetics & Genome Biology program.
On April 23, 2020, the Federal Government committed $40 million to support Genome Canada’s launch of the newly formed Canadian COVID Genomics Network (CanCOGeN). As Canada’s national facility for genome sequencing and analysis, CGEn will lead a nation-wide Host Genome Sequencing Initiative within this framework to sequence genomes of 10,000 Canadians to help understand the genomic architecture of the host response to COVID-19. CGEn is mandated to develop regional, national, and international linkages to ensure that this investment has maximal impact for the health of all Canadians.
Get more details about the project by visiting CGEn website!
The Department of Statistical Sciences at the University of Toronto is a centre for excellence in statistics research and education, both across Canada and internationally. One of Canada’s oldest and largest statistics departments, the department offer students a diverse range of courses, experiental learning experiences, and the opportunity to work with our award-winning faculty. Find out more about the department by visiting the Statistical Sciences Department Website!
The Centre for Applied Genomics (TCAG) is dedicated to conducting and promoting groundbreaking research in genomics including service and training support for academic, government, and private sector scientists worldwide.
For more information on TCAG, visit the TCAG website or Genome Canada website.
LAB150 is a collaboration designed to accelerate drug development. We bring scientists, investors, and company building expertise together to rapidly deliver your concepts to the marketplace.
The mission of LAB150 is three-pronged:
- To develop and identify commercializable assets based on disease-related novel biological pathways
- To significantly shorten the drug discovery timeline and
- To generate viable start-up companies with high potential for success
Find out more about LAB150!
The DLSPH is an internationally recognized community of scientists, teachers, students, practitioners, policy makers and citizens, creating new knowledge, educating change makers, advancing practice and guiding the way to better, more equitable outcomes in population health and health systems – locally, nationally and globally.
To learn more about this program, head to the Dalla Lana School of Public Health website!
SickKids has partnered with Cystic Fibrosis Canada and the SickKids Foundation to develop the Program for Individualized CF Therapy (CFIT).
The CFIT Program is developing tools and technologies for personal medicine in CF. This includes model systems and platforms for in vitro testing of drug responses for people living with cystic fibrosis.
Our program has two major goals:
1. Develop laboratory based tools that will help predict who will respond to CFTR modulators -like ORKAMBI®. We are currently seeking to enroll participants with F508del/F508del prior to starting a CFTR modulator
2. Help in therapy discovery efforts for individuals who have two copies of rare cystic fibrosis-causing mutations.
A open access, online-only journal dedicated to publishing the most important scientific advances in all aspects of genomics and its application in the practice of medicine.